We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

The pharmaceutical company GlaxoSmithKline has asked UK prime minister Tony Blair for patent concessions and tax credits in return for researching drugs for developing countries. The company urged Blair to raise these issues at the UK-led G8 summit next year as part of Britain's focus on healthcare problems in Africa.

According to GlaxoSmithKline's proposal, the creation of drugs for developing world diseases could be rewarded by extending patent-protection on medicines used in rich countries.

Non-governmental organisations are not convinced that this proposal is in everyone's interest, however. Oxfam's senior policy advisor Michael Bailey said patent laws should not be changed because of pressure from industry.

Link to full news story in The Independent